EUVIMEDEUVIMED entdecken
Crossref

Bridged Peptide Analogue of RA-VII, an Antitumor Bicyclic Hexapeptide

Yukio Hitotsuyanagi, Taka-aki Hinosawa, Yoshie Nakagawa, Sho Ito, Ji-Ean Lee, Tomoyo Hasuda

Synlett · 24.01.2023 · 34 (02) · 183-187

DOI: 10.1055/a-1960-4340 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Synlett, erschienen am 24.01.2023. Verfasst von Yukio Hitotsuyanagi und 5 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 28 Literaturangaben. Gefördert von: Japan Society for the Promotion of Science.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

A bridged peptide analogue of RA-VII was designed, in which the α carbons of residues 1 and 4 were linked by a tetramethylene chain to restrict the conformational freedom of the backbone of the 18-membered cyclopeptide. This peptide analogue was synthesized by a ring-closing metathesis reaction of [l-2-allylglycine-1, l-2-allylglycine-4]RA-VII and a subsequent hydrogenation of the resulting olefinic compound. Compared with RA-VII, the analogue showed much weaker cytotoxic activity toward human promyelocytic leukemia HL-60 cells and human colon carcinoma HCT-116 cells, which may be accounted for by the difference in the orientation of the Tyr-6 phenyl ring plane between the analogue and RA-VII.

Förderung

  • Japan Society for the Promotion of Science

Zitieren

APA

Hitotsuyanagi, Y., Hinosawa, T., Nakagawa, Y., Ito, S., Lee, J., & Hasuda, T. (2023). Bridged Peptide Analogue of RA-VII, an Antitumor Bicyclic Hexapeptide. Synlett, 34(02), 183-187. https://doi.org/10.1055/a-1960-4340

Vancouver

Hitotsuyanagi Y, Hinosawa T, Nakagawa Y, Ito S, Lee J, Hasuda T. Bridged Peptide Analogue of RA-VII, an Antitumor Bicyclic Hexapeptide. Synlett. 2023;34(02):183-187. doi:10.1055/a-1960-4340

BibTeX
@article{Hitotsuyanagi2023,
  author = {Hitotsuyanagi, Yukio and Hinosawa, Taka-aki and Nakagawa, Yoshie and Ito, Sho and Lee, Ji-Ean and Hasuda, Tomoyo},
  title = {Bridged Peptide Analogue of RA-VII, an Antitumor Bicyclic Hexapeptide},
  journal = {Synlett},
  year = {2023},
  volume = {34},
  number = {02},
  pages = {183--187},
  doi = {10.1055/a-1960-4340}
}
Kostenlos starten →